OBRIZANDIA Trademark

Trademark Overview


On Friday, February 10, 2017, a trademark application was filed for OBRIZANDIA with the United States Patent and Trademark Office. The USPTO has given the OBRIZANDIA trademark a serial number of 87331188. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 11, 2019. This trademark is owned by Glaxo Group Limited. The OBRIZANDIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
obrizandia

General Information


Serial Number87331188
Word MarkOBRIZANDIA
Filing DateFriday, February 10, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 11, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 13, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 15, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Monday, March 11, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 11, 2019ABANDONMENT - NO USE STATEMENT FILED
Wednesday, July 25, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 23, 2018EXTENSION 2 GRANTED
Monday, July 23, 2018EXTENSION 2 FILED
Monday, July 23, 2018TEAS EXTENSION RECEIVED
Tuesday, December 19, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 15, 2017EXTENSION 1 GRANTED
Friday, December 15, 2017EXTENSION 1 FILED
Friday, December 15, 2017TEAS EXTENSION RECEIVED
Tuesday, August 8, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 13, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 13, 2017PUBLISHED FOR OPPOSITION
Wednesday, May 24, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 4, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 4, 2017ASSIGNED TO EXAMINER
Wednesday, February 15, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 14, 2017NEW APPLICATION ENTERED IN TRAM